Top P.I.'s Say That Their Presence In Labs Acts As Safeguard Against Fraud, Sloppiness

Photo: Youngblood PLAY IT AGAIN: Replication is the key to reducing inadvertent errors or fraudulent results, maintains USC's W. French Anderson. Last fall, Francis Collins, a prolific and widely respected scientist, retracted all or parts of five papers he had coauthored in the preceding two years. Collins, the director of the National Center for Human Genome Research at the National Institutes of Health-which in January became the National Human Genome Research Institute-apparently was the v

Written byBilly Goodman
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Photo: Youngblood PLAY IT AGAIN: Replication is the key to reducing inadvertent errors or fraudulent results, maintains USC's W. French Anderson. Last fall, Francis Collins, a prolific and widely respected scientist, retracted all or parts of five papers he had coauthored in the preceding two years. Collins, the director of the National Center for Human Genome Research at the National Institutes of Health-which in January became the National Human Genome Research Institute-apparently was the victim of a dishonest graduate student in his lab from the University of Michigan, where he had been before coming to NIH. According to published interviews with Collins last fall, the student fabricated and misrepresented data (Notebook, The Scientist, Nov. 11, 1996, page 30). Alerted to possible problems by a journal editor who was considering a paper submitted by Collins and the student, Collins checked some results and redid some work, then confronted the student, who ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies